Travere Therapeutics
The Director, Clinical Science will lead nephrology development activities and clinical programs at Travere Therapeutics, focusing on rare disease therapies. This role involves overseeing clinical trial design and execution, managing data analysis, and ensuring compliance with Good Clinical Practices (GCPs). The position requires collaboration with cross-functional teams to support regulatory submissions and patient-focused innovation.
Headquarters
San Diego, California, United States
Company Size
201-500 employees
Founded
2020
Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life-changing therapies to people living with rare disease.
How Investors Are Reacting To Travere Therapeutics (TVTX) FILSPARI Momentum And Mirum Milestone Windfall
1 day ago
Piper Sandler Increases Target Price for Travere Therapeutics (TVTX)
3 days ago
Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
3 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Travere Therapeutics.
73% above the average for this role
Travere Therapeutics, Inc. (TVTX): A Bull Case Theory
2 weeks ago
Head of Clinical Development (Vice President)
Krystal Biotech
Medical Director, Clinical Research Cardiovascular
Cytokinetics
Senior MSL – Rare Diseases (Haematology, Nephrology and Transplant)
AstraZeneca
Regional Account Manager – Rare Nephrology
AstraZeneca
Medical Science Liaison
Protara Therapeutics
Vice President, Clinical Development
Aurabiosciences